Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 1531-1537

  Ünsal, Cüneyt ^a   Oran, Mustafa ^a   Tureli, Hande Oktay ^b   Alpsoy, Seref ^a   Yeşilyurt, Sema ^c   Arslan, Mehtap ^d   Topcu, Birol ^a   Karakaya, Osman ^e   Kurt, Erhan ^d  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c BAGCILAR TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Bakirkoy Training and Research Hospital for Psychiatry Neurology and Neurosurgery   (Turkey)

^e YALOVA UNIVERSITY   (Turkey)

Author keywords

Ankle brachial index; Carotid intima media thickness; Schizophrenia; Tissue Doppler echocardiography

Indexed keywords

EID: 84885461144     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S52030     Document Type: Article

References (44)

1. Ferrarelli F. Endophenotypes and biological markers and of schizophrenia: from biological signs of illness to novel treatment targets. Curr Pharm Des. Epub February 13, 2013.
2. Heald A. Physical health in schizophrenia: a challenge for antipsychotic therapy. Eur Psychiatry. 2010;25 Suppl 2:S6-S11.
3. Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 2012;25(2):83-88.
4. Lawrence D, Kisely S, Pais J. The epidemiology of excess mortality in people with mental illness. Can J Psychiatry. 2010;55(12): 752-760.
5. Mitchell AJ, Dinan TG. Schizophrenia: a multisystem disease? J Psychopharmacol. 2010;24(Suppl 4):5-7.
6. Bernardo M, Cañas F, Banegas JR, Casademont J, Riesgo Y, Varela C; RICAVA Study Group. Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area. Eur Psychiatry. 2009;24(7):431-441.
7. Bresee LC, Majumdar SR, Patten SB, Johnson JA. Utilization of general and specialized cardiac care by people with schizophrenia. Psychiatr Serv. 2012;63(3):237-242.
8. Jin H, Folsom D, Sasaki A, etal. Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms. Schizophr Res. 2011;125(2-3):295-299.
9. Bresee LC, Majumdar SR, Patten SB, Johnson JA. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res. 2010;117(1):75-82.
10. Bresee LC, Majumdar SR, Patten SB, Johnson JA. Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia. Eur Psychiatry. 2011;26(5):327-332.
11. Callaghan RC, Boire MD, Lazo RG, McKenzie K, Cohn T. Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada. Schizophr Res. 2009;115(2-3):325-332.
12. Ferreira L, Belo A, Abreu-Lima C; RICAVA study group. A case-control study of cardiovascular risk factors and cardiovascular risk among patients with schizophrenia in a country in the low cardiovascular risk region of Europe. Rev Port Cardiol. 2010;29(10):1481-1493.
13. Johnsen E, Gjestad R, Kroken RA, Mellesdal L, Løberg EM, Jørgensen HA. Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study. Nord J Psychiatry. 2011;65(3):192-202.
14. Heald A, Montejo AL, Millar H, De Hert M, McCrae J, Correll CU. Management of physical health in patients with schizophrenia: practical recommendations. Eur Psychiatry. 2010;25 Suppl 2:S41-S45.
15. De Hert M, Vancampfort D, Correll CU, etal. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry. 2011;199(2):99-105.
16. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Curr Opin Cardiol. 2010;25(4):394-398.
17. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25(7):1463-1469.
18. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197-208.
19. Heald CL, Fowkes FG, Murray GD, Price JF; Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis. 2006;189(1):61-69.
20. Peters SA, Grobbee DE, Bots ML. Carotid intima-media thickness: a suitable alternative for cardiovascular risk as outcome? Eur J Cardiovasc Prev Rehabil. 2011;18(2):167-174.
21. Robertson CM, Gerry F, Fowkes R, Price JF. Carotid intima-media thickness and the prediction of vascular events. Vasc Med. 2012;17(4): 239-248.
22. Nagueh SF. Noninvasive evaluation of hemodynamics by Doppler echocardiography. Curr Opin Cardiol. 1999;14(3):217-224.
23. Agarwal R, Gosain P, Kirkpatrick JN, etal. Tissue Doppler imaging for diagnosis of coronary artery disease: a systematic review and meta-analysis. Cardiovasc Ultrasound. 2012;10:47.
24. Hayley BD, Burwash IG. Heart failure with normal left ventricular ejection fraction: role of echocardiography. Curr Opin Cardiol. 2012;27(2):169-180.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
26. Çorapçi{dotless}oǧlu A, Aydemir O, Yi{dotless}ldi{dotless}z M, etal. Structured Clinical Interview for DSM-IV (SCID-IV). Turkish Version. Ankara, Turkey: Hekimler Yayin Birligi; 1999.
27. First MB, Spitzer RL, Gibbon M, Williams, JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1996.
28. Touboul PJ, Hennerici MG, Meairs S, etal. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23(1):75-80.
29. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58(6):1072-1083.
30. Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, Tow DE. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation. 1979;60(4):760-766.
31. Lin HC, Chen YH, Lee HC, Lin HC. Increased risk of acute myocardial infarction after acute episode of schizophrenia: 6 year follow-up study. Aust N Z J Psychiatry. 2010;44(3):273-279.
32. Lahti M, Tiihonen J, Wildgust H, etal. Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia. Psychol Med. 2012:1-11.
33. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
34. Wildgust HJ, Beary M. Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? J Psychopharmacol. 2010;24(Suppl 4):37-50.
35. Kelly DL, McMahon RP, Wehring HJ, etal. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2011;37(4):832-838.
36. Ussher M, Doshi R, Sampuran A, West R. Cardiovascular risk factors in patients with schizophrenia receiving continuous medical care. Community Ment Health J. 2011;47(6):688-693.
37. Raman PG, Thakur BS, Mathew V. Ankle brachial index as a predictor of generalized atherosclerosis. J Assoc Physicians India. 2001;49: 1074-1077.
38. Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Curr Cardiol Rev. 2008;4(2):101-106.
39. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4): 459-467.
40. Pandey AK, Pandey S, Blaha MJ, etal. Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand? Atherosclerosis. 2013;228(2):285-294.
41. Abe Y, Rundek T, Sciacca RR, etal. Ultrasound assessment of subclinical cardiovascular disease in a community-based multiethnic population and comparison to the Framingham score. Am J Cardiol. 2006;98(10): 1374-1378.
42. Gorcsan J 3rd. Tissue Doppler echocardiography. Curr Opin Cardiol. 2000;15(5):323-329.
43. Kjærgaard J. Assessment of right ventricular systolic function by tissue Doppler echocardiography. Dan Med J. 2012;59(3):B4409.
44. Hoffmann S, Mogelvang R, Sogaard P, etal. Tissue Doppler echocardiography reveals impaired cardiac function in patients with reversible ischaemia. Eur J Echocardiogr. 2011;12(8):628-634.